title: Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia.
authors: C
authors: C
authors: Karlsson
authors: H
authors: H
authors: Dahl
authors: J
authors: J
authors: Lundin
authors: E
authors: E
authors: Rossmann
authors: M
authors: M
authors: Brytting
authors: H
authors: H
authors: Mellstedt
authors: A
authors: A
authors: Linde
authors: A
authors: A
authors: Osterborg